Wolfgang Mikulits

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications

Correction: LXRα limits TGFβ-dependent hepatocellular carcinoma associated fibroblast differentiation.

Correction: LXRα limits TGFβ-dependent hepatocellular carcinoma associated fibroblast differentiation.

Journal: Oncogenesis
Published: March 19, 2026

Telomere transcripts act as tumor suppressor and are associated with favorable prognosis in colorectal cancer with low proliferating cell nuclear antigen expression.

Telomere transcripts act as tumor suppressor and are associated with favorable prognosis in colorectal cancer with low proliferating cell nuclear antigen expression.

Journal: Cellular oncology (Dordrecht, Netherlands)
Published: August 16, 2024

YAP1 is a key regulator of EWS::FLI1-dependent malignant transformation upon IGF-1-mediated reprogramming of bone mesenchymal stem cells.

YAP1 is a key regulator of EWS::FLI1-dependent malignant transformation upon IGF-1-mediated reprogramming of bone mesenchymal stem cells.

Journal: Cell reports
Published: August 14, 2024

Tumor-Extrinsic Axl Expression Shapes an Inflammatory Microenvironment Independent of Tumor Cell Promoting Axl Signaling in Hepatocellular Carcinoma.

Tumor-Extrinsic Axl Expression Shapes an Inflammatory Microenvironment Independent of Tumor Cell Promoting Axl Signaling in Hepatocellular Carcinoma.

Journal: International journal of molecular sciences
Published: March 14, 2024

Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma.

Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma.

Journal: Frontiers in oncology
Published: June 12, 2023

Development of an optimized, non-stem cell line for intranasal delivery of therapeutic cargo to the central nervous system.

Development of an optimized, non-stem cell line for intranasal delivery of therapeutic cargo to the central nervous system.

Journal: Molecular oncology
Published: May 30, 2023

PRAME Is a Novel Target of Tumor-Intrinsic Gas6/Axl Activation and Promotes Cancer Cell Invasion in Hepatocellular Carcinoma.

PRAME Is a Novel Target of Tumor-Intrinsic Gas6/Axl Activation and Promotes Cancer Cell Invasion in Hepatocellular Carcinoma.

Journal: Cancers
Published: March 24, 2023

Gas6 in chronic liver disease-a novel blood-based biomarker for liver fibrosis.

Gas6 in chronic liver disease-a novel blood-based biomarker for liver fibrosis.

Journal: Cell death discovery
Published: November 25, 2022

Intrinsic and Extrinsic Control of Hepatocellular Carcinoma by TAM Receptors.

Intrinsic and Extrinsic Control of Hepatocellular Carcinoma by TAM Receptors.

Journal: Cancers
Published: October 01, 2021

Immunological Aspects of AXL/GAS-6 in the Context of Human Liver Regeneration.

Immunological Aspects of AXL/GAS-6 in the Context of Human Liver Regeneration.

Journal: Hepatology communications
Published: March 19, 2021

α2-Adrenergic Receptor in Liver Fibrosis: Implications for the Adrenoblocker Mesedin.

α2-Adrenergic Receptor in Liver Fibrosis: Implications for the Adrenoblocker Mesedin.

Journal: Cells
Published: January 02, 2020

Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver.

Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver.

Journal: Cells
Published: December 23, 2019
Showing 1-12 of 59

Last Updated: 09/26/2026